The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge as a way to speed up the move of intellectual property (IP) from the academic enclave to the marketplace.

The Scottish institution said it is the first university in the United Kingdom to take such a step, which the school described in a press release as part of its libertarian orientation. The technologies will be offered through a Website, Easy Access IP (www.glasgow. ac.uk/technology).

The cancer-related offerings include a telomerase targeted adenoviral suicide-gene therapy vector that has been tested on ovarian cancer cells and a sensor technology called Lab-in- a-Pill that may be used to detect colorectal cancer.